Adult HSCT Unit Northern Centre for Bone Marrow Transplantation Newcastle Tyne UK

Adult Leukaemia and Bone Marrow Transplant Unit Christie NHS Trust Hospital University of Manchester Manchester UK

BMT Unit Inst Português de Oncologia do Porto Porto Portugal

Chaim Sheba Medical Center Tel Aviv University Tel HaShomer Tel Aviv Yafo Israel

Clinical Haematology Department Manchester Royal Infirmary Manchester UK

Clinical Hematology Department Catalan Institute of Oncology Hospital Germans Trias i Pujol Josep Carreras Research Institute Barcelona Spain

Department of Cellular Therapy and Allogeneic Stem Cell Transplantation Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center Stockholm Sweden

Department of Haematological Medicine Kings College Hospital London UK

Department of Haematology The Royal Marsden Hospital London UK

Department of Hematology Amsterdam University Medical Centers Cancer Center Amsterdam and LYMMCARE Amsterdam The Netherlands

Department of Hematology Assistance Publique Hôpitaux de Paris Hopital Saint Louis Paris France

Department of Hematology Erasmus MC Cancer Center Rotterdam The Netherlands

Department of Hematology Hospices Civils de Lyon Lyon Sud Hospital Lyon Pierre Bénite France

Department of Hematology Hospital Clínic Barcelona Spain

Department of Hematology Hospital Univ 12 de Octubre CNIO Complutense University Madrid Spain

Department of Hematology Hospital Universitario de La Princesa Madrid Spain

Department of Hematology Hospital Universitario de Salamanca IBSAL Salamanca Spain

Department of Hematology Institute of Health Research Gregorio Marañon Hospital G Universitario Gregorio Marañon Madrid Spain

Department of Hematology Vall d'Hebron University Hospital Vall d'Hebron Barcelona Spain

Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czechia

Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden

Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

Department of Stem cell Transplantation Princess Maxima Centre for Paediatric Oncology University Medical Centre Utrecht Utrecht The Netherlands

Department of Stem Cell Transplantation University Hospital Eppendorf Hamburg Germany

Dept of Medical Statistics and Bioinformatics EBMT Data Office Leiden The Netherlands

Deptartment of Hematology University Hospital Gasthuisberg Leuven Belgium

Dipartimento di Diagnostica per Immagini Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario A Gemelli IRCCS Roma Italy

Ematologia e Centro Trapianti IRCCS Ospedale Policlinico San Martino Genova Italy

Hematology and BMT Unit IRCCS San Raffaele Scientific Institute Milan Italy

Pediatric Hematology Oncology Azienda Ospedaliera Universitaria Integrata Verona Italy

Zobrazit více v PubMed

Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136:2881–92. doi: 10.1182/blood.2020008824. PubMed DOI PMC

Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021. 10.1038/s41375-021-01302-5. PubMed PMC

Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8:185–93. doi: 10.1016/S2352-3026(20)30429-4. PubMed DOI PMC

Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020;383:2586–8. doi: 10.1056/NEJMc2031670. PubMed DOI PMC

Shah GL, DeWolf S, Lee YJ, Tamari R, Dahi PB, Lavery JA, et al. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation. J Clin Investig. 2020;130:6656–67. doi: 10.1172/JCI141777. PubMed DOI PMC

Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, et al. Intractable coronavirus disease 2019 (COVID-19) and prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in a chimeric antigen receptor-modified T-cell therapy recipient: a case study. Clin Infect Dis. 2021;73:e815–21. doi: 10.1093/cid/ciab072. PubMed DOI PMC

Mushtaq MU, Shahzad M, Chaudhary SG, Luder M, Ahmed N, Abdelhakim H, et al. Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients. Transplant Cell Ther. 2021;27:796.e1–7. doi: 10.1016/j.jtct.2021.07.005. PubMed DOI PMC

Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T, et al. Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy. Am J Hematol. 2021;96:934–44. doi: 10.1002/ajh.26209. PubMed DOI PMC

Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T, et al. Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study. Hemasphere. 2021;5:e538. doi: 10.1097/HS9.0000000000000538. PubMed DOI PMC

Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021;27:1280–9. doi: 10.1038/s41591-021-01386-7. PubMed DOI PMC

Thakkar A, Pradhan K, Jindal S, Cui Z, Rockwell B, Pradip Shah A, et al. Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy. Nat Cancer. 2021;2:392–9. doi: 10.1038/s43018-021-00191-y. PubMed DOI PMC

Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 Variants in Patients with Immunosuppression. N Engl J Med. 2021;385:562–6. doi: 10.1056/NEJMsb2104756. PubMed DOI PMC

Corti D, Purcell LA, Snell G, Veesler D. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021;184:3086–108. doi: 10.1016/j.cell.2021.05.005. PubMed DOI PMC

Maneikis K, Šablauskas K, Ringelevičiūtė U, Vaitekėnaitė V, Čekauskienė R, Kryžauskaitė L, et al. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021;8:e583–92. doi: 10.1016/S2352-3026(21)00169-1. PubMed DOI PMC

Greenberger LM, Saltzman LA, Senefeld JW, Johnson PW, DeGennaro LJ, Nichols GL. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies. Cancer Cell. 2021;39:1031–3. doi: 10.1016/j.ccell.2021.07.012. PubMed DOI PMC

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry